DIRECT COMPARISON OF EFFECTIVENESS AND SAFETY OF TOFACITINIB AND BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-WORLD SETTINGS

被引：0
|
作者：
Iwamoto, N. [1 ]
Suzuki, T. [2 ]
Okada, A. [3 ]
Fujikawa, K. [4 ]
Aramaki, T. [5 ]
Mizokami, A. [4 ]
Ueki, Y. [5 ]
Kawakami, A. [1 ]
机构：
[1] Nagasaki Univ, Grad Sch Biomed Sci, Div Adv Prevent Med Sci, Dept Immunol & Rheumatol, Nagasaki, Japan
[2] Sasebo City Gen Hosp, Dept Internal Med, Sasebo, Japan
[3] Nagasaki Atom Bomb Museum, Dept Rheumatol, Nagasaki, Japan
[4] Japan Community Healthcare Org, Isahaya Gen Hosp, Dept Rheumatol, Isahaya, Japan
[5] Sasebo Chuo Hosp, Dept Rheumatol, Sasebo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.3469
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0674
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [21] ADAPTABILITY, EFFECTIVENESS AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rodriguez, Fernando
    Aza, Anggie
    Cabrera, Michael
    Santos-Moreno, Pedro
    Buitrago-Garcia, Diana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 2154 - 2154
  • [22] Tofacitinib for the treatment of rheumatoid arthritis: a real-world study in China
    Yunzhen Shi
    Yuesheng Xie
    Guangfeng Zhang
    Yuan Feng
    Internal and Emergency Medicine, 2022, 17 : 703 - 714
  • [23] Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
    Bertoldi, Ilaria
    Caporali, Roberto
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2021, 13 : 221 - 237
  • [24] Tofacitinib for the treatment of rheumatoid arthritis: a real-world study in China
    Shi, Yunzhen
    Xie, Yuesheng
    Zhang, Guangfeng
    Feng, Yuan
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (03) : 703 - 714
  • [25] REAL-WORLD EFFECTIVENESS OF FILGOTINIB IN BELGIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Diederik, D. C.
    Durez, P.
    Lenaerts, J.
    Westhovens, R.
    Verschueren, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1401 - 1401
  • [26] Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
    Lee, Young Ho
    Song, Gwan Gyu
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (08): : 785 - 796
  • [27] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    Pereira, Candida da Fonseca
    Witcombe, David
    Griffiths, Hedley
    CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2545 - 2551
  • [28] Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia
    Paul Bird
    Geoffrey Littlejohn
    Belinda Butcher
    Tegan Smith
    Candida da Fonseca Pereira
    David Witcombe
    Hedley Griffiths
    Clinical Rheumatology, 2020, 39 : 2545 - 2551
  • [29] Real-World Evidence on the Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis in Lebanon
    Sharara, Ala I.
    Alrazim, Ayman
    Saniour, Philippe
    Daniel, Fady
    Rached, Antoine Abou
    Bahr, Abbas
    Azar, Cecilio
    Geagea, Antoine
    Ghoubar, Marcelle
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S858 - S859
  • [30] Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
    Lair-Mehiri, Loriane
    Stefanescu, Carmen
    Vaysse, Thibaut
    Laharie, David
    Roblin, Xavier
    Rosa, Isabelle
    Treton, Xavier
    Abitbol, Vered
    Amiot, Aurelien
    Bouguen, Guillaume
    Dib, Nina
    Fumery, Mathurin
    Pariente, Benjamin
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Simon, Marion
    Viennot, Stephanie
    Bouhnik, Yoram
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (03) : 268 - 273
12345